TR200200415T2 - İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler. - Google Patents

İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.

Info

Publication number
TR200200415T2
TR200200415T2 TR2002/00415T TR200200415T TR200200415T2 TR 200200415 T2 TR200200415 T2 TR 200200415T2 TR 2002/00415 T TR2002/00415 T TR 2002/00415T TR 200200415 T TR200200415 T TR 200200415T TR 200200415 T2 TR200200415 T2 TR 200200415T2
Authority
TR
Turkey
Prior art keywords
substituted
esters derived
new esters
compounds
phenylcyclohexyl
Prior art date
Application number
TR2002/00415T
Other languages
English (en)
Inventor
Carlos Del Castillo Nieto Juan
Huguet Clotet Joan
De Ramon Amat Elisabeth
Chalaux Freixa Maria
Mourella Mancini Marisabel
Original Assignee
Vita Invest, S.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest, S.A filed Critical Vita Invest, S.A
Publication of TR200200415T2 publication Critical patent/TR200200415T2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C219/30Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Tramadol'den elde edilen ikame fenil sikoheksil bilesimlerinden elde edilen yeni esterler; bunlarin elde edilme islemi ve analjezik özelliklere sahip olan ilacin hazirlanmasinda bunlarin kullanimi. Genel formülün (I) bu yeni bilesenleri daha yüksek bir analjezik aktiviteye, daha az toksiteye ve daha uzun bir etkinlik zamanina sahiptir.
TR2002/00415T 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler. TR200200415T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802329A ES2141688B1 (es) 1998-11-06 1998-11-06 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.

Publications (1)

Publication Number Publication Date
TR200200415T2 true TR200200415T2 (tr) 2002-06-21

Family

ID=8305698

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2002/00415T TR200200415T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
TR2002/00416T TR200200416T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
TR2001/01160T TR200101160T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2002/00416T TR200200416T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
TR2001/01160T TR200101160T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.

Country Status (39)

Country Link
US (1) US6455585B1 (tr)
EP (3) EP1219594B1 (tr)
JP (1) JP2002529442A (tr)
KR (1) KR100453613B1 (tr)
CN (1) CN1176902C (tr)
AP (1) AP1222A (tr)
AT (3) ATE257817T1 (tr)
AU (1) AU755681B2 (tr)
BG (1) BG105556A (tr)
BR (1) BR9915727A (tr)
CA (1) CA2349245A1 (tr)
CR (1) CR6368A (tr)
CU (1) CU23006A3 (tr)
CZ (1) CZ20011500A3 (tr)
DE (3) DE69914229T2 (tr)
DK (3) DK1219594T3 (tr)
EA (1) EA003742B1 (tr)
EE (1) EE200100246A (tr)
ES (4) ES2141688B1 (tr)
GE (1) GEP20033116B (tr)
HR (1) HRP20010412B1 (tr)
HU (1) HUP0104218A3 (tr)
ID (1) ID29017A (tr)
IL (1) IL142592A0 (tr)
IS (1) IS5934A (tr)
MA (1) MA26765A1 (tr)
MX (1) MXPA01004432A (tr)
NO (1) NO20012234D0 (tr)
NZ (1) NZ511739A (tr)
OA (1) OA11672A (tr)
PL (1) PL347492A1 (tr)
PT (3) PT1219623E (tr)
SI (3) SI1127871T1 (tr)
SK (1) SK284068B6 (tr)
TR (3) TR200200415T2 (tr)
UA (1) UA59477C2 (tr)
WO (1) WO2000027799A1 (tr)
YU (1) YU29601A (tr)
ZA (1) ZA200104026B (tr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160534B1 (es) * 1999-12-30 2002-04-16 Vita Invest Sa Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
AU2003264311A1 (en) * 2002-08-28 2004-04-08 Jin Wang Oral formulations of ibuprofen and tramadol, methods and preparation thereof
EP3241550B1 (de) 2002-11-22 2020-07-22 Grünenthal GmbH (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol zur behandlung von entzündungsschmerz
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102004034619A1 (de) * 2004-07-16 2006-02-23 Grünenthal GmbH Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
CN102014877B (zh) 2008-01-25 2017-06-06 格吕伦塔尔有限公司 药物剂型
KR101690094B1 (ko) 2008-05-09 2016-12-27 그뤼넨탈 게엠베하 분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법
NZ596667A (en) 2009-07-22 2013-09-27 Gruenenthal Chemie Hot-melt extruded controlled release dosage form
TWI473628B (zh) 2009-07-22 2015-02-21 用於對氧化敏感之類鴉片藥劑之抗破壞劑型
EP2383255A1 (en) * 2010-04-28 2011-11-02 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
CN103269688A (zh) 2010-09-02 2013-08-28 格吕伦塔尔有限公司 包含无机盐的抗破碎剂型
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
WO2012100423A1 (en) * 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
NO2736495T3 (tr) 2011-07-29 2018-01-20
NO2736497T3 (tr) 2011-07-29 2018-01-20
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
RS57913B1 (sr) 2012-04-18 2019-01-31 Gruenenthal Gmbh Farmaceutske dozne forme otporne na neovlašćenu upotrebu i naglo oslobađanje celokupne doze
US9339484B2 (en) * 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 1個または複数の粒子を含有する改変防止(tamper−resistant)剤形
BR112015029616A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem resistente à adulteração com perfil de liberação bimodal
EP3019157A1 (en) 2013-07-12 2016-05-18 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US20160310429A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe

Also Published As

Publication number Publication date
WO2000027799A1 (es) 2000-05-18
ES2141688A1 (es) 2000-05-16
HRP20010412A2 (en) 2002-12-31
HUP0104218A2 (hu) 2002-03-28
PT1219623E (pt) 2004-04-30
ID29017A (id) 2001-07-26
DK1127871T3 (da) 2003-11-24
ES2213732T3 (es) 2004-09-01
PT1219594E (pt) 2004-04-30
EP1127871A1 (en) 2001-08-29
AU755681B2 (en) 2002-12-19
EP1219594A1 (en) 2002-07-03
HRP20010412B1 (en) 2004-04-30
ATE257817T1 (de) 2004-01-15
DK1219623T3 (da) 2004-04-19
EE200100246A (et) 2002-12-16
CR6368A (es) 2002-04-08
SI1219594T1 (en) 2004-06-30
SK5842001A3 (en) 2001-12-03
AU1047300A (en) 2000-05-29
EP1219594B1 (en) 2004-01-14
EA200100476A1 (ru) 2002-02-28
CZ20011500A3 (cs) 2001-09-12
BR9915727A (pt) 2001-09-04
MXPA01004432A (es) 2002-09-18
GEP20033116B (en) 2003-11-25
IL142592A0 (en) 2002-03-10
SI1219623T1 (en) 2004-06-30
DK1219594T3 (da) 2004-04-19
EP1219623A1 (en) 2002-07-03
CN1176902C (zh) 2004-11-24
ES2213731T3 (es) 2004-09-01
ES2207298T3 (es) 2004-05-16
ATE249418T1 (de) 2003-09-15
JP2002529442A (ja) 2002-09-10
DE69911235T2 (de) 2004-07-01
DE69914231D1 (de) 2004-02-19
ATE257837T1 (de) 2004-01-15
BG105556A (en) 2001-12-29
IS5934A (is) 2001-05-03
EP1219623B1 (en) 2004-01-14
CA2349245A1 (en) 2000-05-18
AP1222A (en) 2003-11-06
MA26765A1 (fr) 2004-12-20
OA11672A (en) 2005-01-12
EP1127871B1 (en) 2003-09-10
CU23006A3 (es) 2004-12-17
NO20012234L (no) 2001-05-04
SK284068B6 (sk) 2004-09-08
ZA200104026B (en) 2002-05-17
TR200101160T2 (tr) 2002-01-21
TR200200416T2 (tr) 2003-01-21
NZ511739A (en) 2002-11-26
EA003742B1 (ru) 2003-08-28
HUP0104218A3 (en) 2002-11-28
CN1325377A (zh) 2001-12-05
DE69914229T2 (de) 2004-12-09
KR20010080942A (ko) 2001-08-25
YU29601A (sh) 2003-04-30
UA59477C2 (uk) 2003-09-15
ES2141688B1 (es) 2001-02-01
PL347492A1 (en) 2002-04-08
NO20012234D0 (no) 2001-05-04
KR100453613B1 (ko) 2004-10-20
DE69914229D1 (de) 2004-02-19
PT1127871E (pt) 2003-12-31
DE69911235D1 (de) 2003-10-16
SI1127871T1 (en) 2004-02-29
DE69914231T2 (de) 2004-11-11
US6455585B1 (en) 2002-09-24

Similar Documents

Publication Publication Date Title
TR200200415T2 (tr) İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
TR199901653T2 (tr) Fitalazinonlar.
TR200003333T2 (tr) Ensülin direngenliği ve hiperglisemi tedavisinde yararlı benzotiyofenler
PT841929E (pt) Quinolonas e sua utilizacao terapeutica
ATE270817T1 (de) Fungizide
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
YU48701A (sh) Fenilfenantridini sa dejstvom inhibicije pde-iv
WO2006084030A3 (en) Small-molecule hsp90 inhibitors
TR200400376T4 (tr) Yeni, ilaç olarak kullanılabilen antikolinerjikler ve bunların imalatı için yöntem
TR199901674T2 (tr)
PT1506185E (pt) Compostos novos e sua utilizacao
BR9609888A (pt) Halogenobenzimidazóis
GEP20084488B (en) Use of therapeutic agents for treating pain
BR9610960A (pt) Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
NO992282D0 (no) Benzonaftyridiner som bronkialterapentika
FR2712591B1 (fr) Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
GEP20022654B (en) Indazole Amide Compounds As Serotoninergic Agents
SE9804212D0 (sv) Compounds
ATE297903T1 (de) Substituierte phenyluracile
DK1086096T3 (da) Benzamider med tetrahydrofuranyloxy-substituenter som inhibitorer af phosphodiesterase 4
HUP0105280A2 (hu) Benzaldehidszármazékok és gyógyászati alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
ATE169921T1 (de) Optisch aktive beta-aminoalkoxyborankomplexe
DK0696278T3 (da) Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
TR200402650T4 (tr) Yeni positif alosterik ampa-reseptör modülatörleri (paarm), bunların imalatı için yöntem ve bunların ilaç olarak kullanımları